Clinical Trials in Texas

Showing 3381-3400 of 9,682 trials

Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen?

NCT06505148

To examine the difference in pain control in the pediatric general surgery population alternating acetaminophen and Ibuprofen q 3 hours vs giving them simultaneous combination therapy around the clock.

Pediatric Disorder

Baylor Research Institute80 participantsStarted Aug 2024

Temple, Texas, United States

COMPLETEDPhase 243 miles

A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat

NCT05736107

This is a randomized, placebo-controlled, Phase 2b study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing subcutaneous fat.

Subcutaneous Fat

Caliway Biopharmaceuticals Co., Ltd.107 participantsStarted May 2023

Pflugerville, Texas, United States

COMPLETEDNA43 miles

Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults

NCT05908825

This is a split-face, double-blind, placebo-controlled study assessing the use of a novel exfoliative serum with a chemical peel to improve photodamage in healthy female subjects between the ages of 30 and 65 years, inclusive, with Fitzpatrick skin types I-VI.

Photodamaged Skin

Austin Institute for Clinical Research34 participantsStarted Jun 2023

Pflugerville, Texas, United States

Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen?

A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat

Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults

Find Trials by Condition in Texas

Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults

Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo

A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE

Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis

A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants

Oral Nutritional Supplementation in Children at Risk of Undernutrition

Belimumab Assessment of Safety in SLE

Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Metastatic Solid Cancer Clinical Trial

Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials

C-myc Biomarker Study for Diabetic Foot Ulcers

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine